Clinical Trial in India - WorkSure
Clinical trials are the scientific term used for testing of newly evaluated drug and to know the safety and efficacy of that new drug. Medical trials are not only an important step in drug development but also a decisive factor for the fate of the drug. The clinical trials are conducted to know the safety and effectiveness of the new drug and to know the clinical use the drug with the involving of the human subjects. Indicating the rapid elevation of the India as one of the world's leading destinations for clinical trials there are a host of reasons for India being a preferred location for trials.
India offers unique opportunities for conducting medical trials due to a significant cost reduction and increased speed and productivity of all R&D phases required to bring a safe and effective drug to market. In the last few years, there has been considerable growth and dramatic changes noted in the regulatory aspects for conducting medical trial in India.
This article aims to elaborate on the factors which have thrust India in the forefront as a preferred destination for clinical trials.
Rise of Clinical Research Market
The Clinical Research Organization industry emerged in the late 1990s when the pharmaceutical Research & Development began to face stiff competition in various areas. At the outset, the US predominated as a leader in the Clinical Research industry. Since it was home to the world's largest drug industry and also because of the favorable regulatory environment it had. With patient recruitment becoming a crucial factor in deciding the cost of a clinical trial, the CRO industry started looking out for newer pastures for clinical trials, when the concept of €outsourcing€ emerged in the horizon. Currently the top five global clinical trial markets include the US, Germany, France, Canada and Spain. India's clinical trial market has shown significant growth in the last 5 years.
India boasts of some of the best medical talent, comparable with those from the developed countries of the world. The Indian Physicians are adept in the conduct of clinical trials and are some of the most sought-after Key Opinion Leaders (KoLs). India has a sound medical infrastructure, capable of delivering reliable and quality data.
The CRO industry in the Indian sub-continent has had its own share of trials and tribulations. A concerted effort by the industry and the regulatory authorities has sorted many issues. Indian trials are mainly fraught with issues pertaining to patient inclusion, subject compliance and skepticism, which is usually unavoidable in a scientific experiment of this magnitude.
India offers unique opportunities for conducting medical trials due to a significant cost reduction and increased speed and productivity of all R&D phases required to bring a safe and effective drug to market. In the last few years, there has been considerable growth and dramatic changes noted in the regulatory aspects for conducting medical trial in India.
This article aims to elaborate on the factors which have thrust India in the forefront as a preferred destination for clinical trials.
Rise of Clinical Research Market
The Clinical Research Organization industry emerged in the late 1990s when the pharmaceutical Research & Development began to face stiff competition in various areas. At the outset, the US predominated as a leader in the Clinical Research industry. Since it was home to the world's largest drug industry and also because of the favorable regulatory environment it had. With patient recruitment becoming a crucial factor in deciding the cost of a clinical trial, the CRO industry started looking out for newer pastures for clinical trials, when the concept of €outsourcing€ emerged in the horizon. Currently the top five global clinical trial markets include the US, Germany, France, Canada and Spain. India's clinical trial market has shown significant growth in the last 5 years.
India boasts of some of the best medical talent, comparable with those from the developed countries of the world. The Indian Physicians are adept in the conduct of clinical trials and are some of the most sought-after Key Opinion Leaders (KoLs). India has a sound medical infrastructure, capable of delivering reliable and quality data.
The CRO industry in the Indian sub-continent has had its own share of trials and tribulations. A concerted effort by the industry and the regulatory authorities has sorted many issues. Indian trials are mainly fraught with issues pertaining to patient inclusion, subject compliance and skepticism, which is usually unavoidable in a scientific experiment of this magnitude.
